Global Gonadotropin-releasing Hormone Antagonists Market Research Report 2021

1 Gonadotropin-releasing Hormone Antagonists Market Overview

• 1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Antagonists
• 1.2 Gonadotropin-releasing Hormone Antagonists Segment by Type
  • 1.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Peptides
  • 1.2.3 Small Molecules
• 1.3 Gonadotropin-releasing Hormone Antagonists Segment by Application
  • 1.3.1 Global Gonadotropin-releasing Hormone Antagonists Sales Comparison by Application: (2021-2027)
  • 1.3.2 Prostate Cancer
  • 1.3.3 Endometriosis
  • 1.3.4 Uterine Fibroids
  • 1.3.5 Female Infertility
  • 1.3.6 Others
• 1.4 Global Gonadotropin-releasing Hormone Antagonists Market Size Estimates and Forecasts
  • 1.4.1 Global Gonadotropin-releasing Hormone Antagonists Revenue 2016-2027
  • 1.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales 2016-2027
  • 1.4.3 Gonadotropin-releasing Hormone Antagonists Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gonadotropin-releasing Hormone Antagonists Market Competition by Manufacturers

• 2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Gonadotropin-releasing Hormone Antagonists Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Gonadotropin-releasing Hormone Antagonists Manufacturing Sites, Area Served, Product Type
• 2.5 Gonadotropin-releasing Hormone Antagonists Market Competitive Situation and Trends
  • 2.5.1 Gonadotropin-releasing Hormone Antagonists Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue
  • 2.5.3 Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario by Region

• 3.1 Global Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
  • 3.3.1 North America Gonadotropin-releasing Hormone Antagonists Sales by Country
  • 3.3.2 North America Gonadotropin-releasing Hormone Antagonists Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
  • 3.4.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country
  • 3.4.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region
  • 3.5.2 Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
  • 3.6.1 Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country
  • 3.6.2 Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country
  • 3.7.2 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Gonadotropin-releasing Hormone Antagonists Historic Market Analysis by Type

• 4.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
• 4.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2016-2021)
• 4.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2016-2021)

5 Global Gonadotropin-releasing Hormone Antagonists Historic Market Analysis by Application

• 5.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
• 5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2016-2021)
• 5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 AbbVie
  • 6.1.1 AbbVie Corporation Information
  • 6.1.2 AbbVie Description and Business Overview
  • 6.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.1.5 AbbVie Recent Developments/Updates
• 6.2 Takeda
  • 6.2.1 Takeda Corporation Information
  • 6.2.2 Takeda Description and Business Overview
  • 6.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.2.5 Takeda Recent Developments/Updates
• 6.3 Astellas
  • 6.3.1 Astellas Corporation Information
  • 6.3.2 Astellas Description and Business Overview
  • 6.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.3.5 Astellas Recent Developments/Updates
• 6.4 Kissei
  • 6.4.1 Kissei Corporation Information
  • 6.4.2 Kissei Description and Business Overview
  • 6.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.4.5 Kissei Recent Developments/Updates
• 6.5 Veru Inc
  • 6.5.1 Veru Inc Corporation Information
  • 6.5.2 Veru Inc Description and Business Overview
  • 6.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.5.5 Veru Inc Recent Developments/Updates
• 6.6 Myovant Sciences
  • 6.6.1 Myovant Sciences Corporation Information
  • 6.6.2 Myovant Sciences Description and Business Overview
  • 6.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.6.5 Myovant Sciences Recent Developments/Updates
• 6.7 AstraZeneca
  • 6.6.1 AstraZeneca Corporation Information
  • 6.6.2 AstraZeneca Description and Business Overview
  • 6.6.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.7.5 AstraZeneca Recent Developments/Updates
• 6.8 Ferring Pharmaceuticals
  • 6.8.1 Ferring Pharmaceuticals Corporation Information
  • 6.8.2 Ferring Pharmaceuticals Description and Business Overview
  • 6.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.8.5 Ferring Pharmaceuticals Recent Developments/Updates
• 6.9 Jiangsu Hengrui Medicine Co
  • 6.9.1 Jiangsu Hengrui Medicine Co Corporation Information
  • 6.9.2 Jiangsu Hengrui Medicine Co Description and Business Overview
  • 6.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
  • 6.9.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates

7 Gonadotropin-releasing Hormone Antagonists Manufacturing Cost Analysis

• 7.1 Gonadotropin-releasing Hormone Antagonists Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Antagonists
• 7.4 Gonadotropin-releasing Hormone Antagonists Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Gonadotropin-releasing Hormone Antagonists Distributors List
• 8.3 Gonadotropin-releasing Hormone Antagonists Customers

9 Gonadotropin-releasing Hormone Antagonists Market Dynamics

• 9.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
• 9.2 Gonadotropin-releasing Hormone Antagonists Growth Drivers
• 9.3 Gonadotropin-releasing Hormone Antagonists Market Challenges
• 9.4 Gonadotropin-releasing Hormone Antagonists Market Restraints

10 Global Market Forecast

• 10.1 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Type (2022-2027)
• 10.2 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Application (2022-2027)
• 10.3 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List